Legal implications of drug testing in the workplace.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to L M Simonsmeier.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Adverse drug interactions have always been of concern to the physician and pharmacist. Recently such events have been used as the basis for malpractice suits involving health professionals. Pharmacists have both a professional duty to avert such interactions if possible and a legal duty to know their responsibilities in this area. Patient counseling, the maintenance of patient profiles, and familiarity with the drug interaction literature through continuing education opportunities can aid pharmacists in detecting or preventing adverse interactions, while familiarity with the liability laws can help pharmacists protect their practices.
Explore the source record for details and available documents.
The implications of the 1978 U.S. Supreme Court decision in Marshall vs. Barlow's, Inc., regarding warrantless inspections of pharmacies are discussed. Reviewed are the Fourth Amendment to the U.S. Constitution, related U.S. Supreme Court decisions (Camera vs. Municipal Court and See vs. City of Seattle), new "probable cause" standards, and exceptions to the requirement of warrants for inspections. The effect of the Barlow's case with specific reference to FDA, DEA and state board of pharmacy inspections is discussed. Although the Barlow's case has provided further case law in the area of administrative inspections, each case still requires individual resolution. DEA inspections are well delineated by statute and regulation. Under the "licensing exceptions," warrantless pharmacy inspections by the FDA and by boards of pharmacy are probably permissible.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.